Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Low vitamin D levels in patients with migraine

Publish date:: June 23, 2020

Key clinical point: Serum levels of 25-hydroxyvitamin D (25(OH)D) are lower in patients with migraine than healthy individuals.

Major finding: Serum levels of 25(OH)D were significantly lower in patients with migraine than control individuals (random effects model: mean difference, −4.05; 95% confidence interval, −6.34 to −1.76).

Study details: Meta-analysis of 8 studies including 8,965 participants (952 patients with migraine and 8,013 healthy controls).

Disclosures: No study sponsor was identified. The authors declared no competing interest.

Citation:

Liampas I et al. Rev Neurol. 2020 Mar 30. doi: 10.1016/j.neurol.2019.12.008.

This Week's Must Reads

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Study links sleep meds and dementia risk in older adults,

Childhood Hodgkin survivors have neurocognitive impairment,

Obesity, hypoxia predict severity in children with COVID-19,

Long-term safety and efficacy of teriflunomide for relapsing MS,

Must Reads in Headache & Migraine

HIT-6 may help track meaningful change in chronic migraine,

Choroid plexuses may play a role in migraine,

Multiple traits more common in difficult-to-treat patients with migraine,

Marijuana for migraine? Some tentative evidence,

Low vitamin D levels in patients with migraine,